To explore the safety warning signals of dienogest in the FDA adverse event reporting system (FAERS) and to provide reference for clinical safe drug use.
The reports related to dienogest collected from the FAERS database from the first quarter of 2004 to the first quarter of 2022 were searched for adverse event signals by using the reporting odds ratio method in disproportionality analysis. The term set of the International Dictionary of Medical Terms was used for sinicization and analysis.
The number of adverse event reports with dienogest as the primary suspect drug was 790 reports with 66 signals. The safety signals were pulmonary embolism after operation, cerebellar stroke, mixed anxiety and depression disorder, Steele's disease and venous embolism. It mainly involves vascular and lymphatic diseases, respiratory system, chest and mediastinal diseases, various injuries, poisoning and operational complications.
The FAERS database can be used to comprehensively analyze and study the adverse events of dienogest after marketing, and provide a basis for safe and rational clinical drug use. When using dienogest in clinic, we should pay close attention to the vascular and lymphatic diseases of the drug, and take intervention measures as soon as possible to ensure the safe and effective use of the drug.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |